Cargando…
PLOD3 suppression exerts an anti-tumor effect on human lung cancer cells by modulating the PKC-delta signaling pathway
Current lung cancer treatments are far from satisfactory; thus, finding novel treatment targets is crucial. We recently identified procollagen-lysine, 2-oxoglutarate 5-dioxygenase 3 (PLOD3), which is involved in fibrosis and tissue remodeling as a radioresistance-related protein in lung cancer cells...
Autores principales: | Baek, Jeong-Hwa, Yun, Hong Shik, Kwon, Gyoo Taik, Lee, Janet, Kim, Ju-Young, Jo, Yunhui, Cho, Jae-Min, Lee, Chang-Woo, Song, Jie-Young, Ahn, Jiyeon, Kim, Jae-Sung, Kim, Eun Ho, Hwang, Sang-Gu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6377650/ https://www.ncbi.nlm.nih.gov/pubmed/30770789 http://dx.doi.org/10.1038/s41419-019-1405-8 |
Ejemplares similares
-
PLOD3 promotes lung metastasis via regulation of STAT3
por: Baek, Jeong-Hwa, et al.
Publicado: (2018) -
PB1798: EVALUATION OF EXPRESSION OF PLODS FAMILY GENES (PLOD1, PLOD2, PLOD3) IN PATIENTS WITH ACUTE MYELOID LEUKEMIA
por: Zaker, F., et al.
Publicado: (2022) -
A novel function of HRP‐3 in regulating cell cycle progression via the HDAC–E2F1–Cyclin E pathway in lung cancer
por: Yun, Hong Shik, et al.
Publicado: (2021) -
Kinesin light chain 4 as a new target for lung cancer chemoresistance via targeted inhibition of checkpoint kinases in the DNA repair network
por: Baek, Jeong-Hwa, et al.
Publicado: (2020) -
MKI-1, a Novel Small-Molecule Inhibitor of MASTL, Exerts Antitumor and Radiosensitizer Activities Through PP2A Activation in Breast Cancer
por: Kim, Ah-Young, et al.
Publicado: (2020)